Maintenance therapy in chronic lymphocytic leukaemia

被引：0
作者：
Delgado, Julio [1 ]
Montserrat, Emili [1 ]
机构：
[1] Univ Barcelona, Hosp Clin, Inst Haematol & Oncol, Dept Haematol, E-08036 Barcelona, Spain
来源：
LANCET HAEMATOLOGY | 2016年 / 3卷 / 09期
关键词：
RITUXIMAB; CHEMOIMMUNOTHERAPY; LENALIDOMIDE; TRIAL;
D O I：
10.1016/S2352-3026(16)30081-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E399 / E400
页数：2
相关论文
共 50 条
  • [31] Minimal residual disease in chronic lymphocytic leukaemia
    Garcia Vela, Jose Antonio
    Garcia Marco, Jose Antonio
    MEDICINA CLINICA, 2018, 150 (04): : 144 - 149
  • [32] ASH update 2010: Chronic lymphocytic leukaemia
    Steurer, M.
    Schmidt, S.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2011, 4 (02) : 117 - 119
  • [33] ASH update 2010: Chronic lymphocytic leukaemia
    M. Steurer
    S. Schmidt
    memo - Magazine of European Medical Oncology, 2011, 4 (2) : 117 - 119
  • [34] Autoimmune Complications in Chronic Lymphocytic Leukaemia (CLL)
    Zent, Clive S.
    Kay, Neil E.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2010, 23 (01) : 47 - 59
  • [35] Ibrutinib in chronic lymphocytic leukaemia: alone or in combination?
    Robak, Tadeusz
    LANCET ONCOLOGY, 2016, 17 (02) : 129 - 131
  • [36] Lenalidomide maintenance in high risk chronic lymphocytic leukaemia: practice changing study or hypothesis generating approach?
    Rossi, Davide
    Condoluci, Adalgisa
    LANCET HAEMATOLOGY, 2017, 4 (10): : E455 - E456
  • [37] Rituximab in combination with chemotherapy for the treatment of chronic lymphocytic leukaemia in clinical practice
    Reiser, Marcel
    Doerfel, Steffen
    Hensel, Manfred
    Hoesl, Mark
    Jordan, Wolf-Oliver
    Koenigsmann, Michael
    Meyer, Dirk
    Reichert, Dietmar
    Schwarzer, Andreas
    Marquardt, Moritz
    Kellershohn, Kerstin
    Jentsch-Ullrich, Kathleen
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 100 (05) : 455 - 464
  • [38] Management of patients with previously untreated chronic lymphocytic leukaemia with obinutuzumab and chlorambucil
    Tam, Constantine
    Kuss, Bryone
    Opat, Stephen
    Boulos, Joy
    Marlton, Paula
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 5 - 10
  • [39] Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia
    Simkovic, Martin
    Vodarek, Pavel
    Motyckova, Monika
    ecsiova, Dominika
    Rozsivalova, Petra
    Mocikova, Heidi
    Stepankova, Pavla
    Sykorova, Alice
    Hrochova, Katerina
    Vrbacky, Filip
    Belada, David
    Zak, Pavel
    Smolej, Lukas
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 (04)
  • [40] Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study
    van Oers, Marinus H. J.
    Kuliczkowski, Kazimierz
    Smolej, Lukas
    Petrini, Mario
    Offner, Fritz
    Grosicki, Sebastian
    Levin, Mark-David
    Gupta, Ira
    Phillips, Jennifer
    Williams, Vanessa
    Manson, Stephanie
    Lisby, Steen
    Geisler, Christian
    LANCET ONCOLOGY, 2015, 16 (13) : 1370 - 1379
12345